Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights

Shivani Handa; Kyle A. Farina; Michelle Becker; Brianna Kelly; Ashley Yu; Jonathan Feld; Douglas Tremblay; Bridget K. Marcellino; Christian Salib; John Mascarenhas; Alan H. Shih

doi:10.1200/PO.23.00234

Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights

Shivani Handa
, Kyle A. Farina
, Michelle Becker
, Brianna Kelly
, Ashley Yu
, Jonathan Feld
, Douglas Tremblay
, Bridget K. Marcellino
, Christian Salib
, John Mascarenhas
, Alan H. Shih

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Original language	English
Article number	e2300234
Journal	JCO Precision Oncology
Volume	8
DOIs	https://doi.org/10.1200/PO.23.00234
State	Published - 1 Jan 2024

Access to Document

10.1200/PO.23.00234

Cite this

@article{08ab5aa49ff64dff8978c7ca904b4643,

title = "Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights",

author = "Shivani Handa and Farina, \{Kyle A.\} and Michelle Becker and Brianna Kelly and Ashley Yu and Jonathan Feld and Douglas Tremblay and Marcellino, \{Bridget K.\} and Christian Salib and John Mascarenhas and Shih, \{Alan H.\}",

year = "2024",

month = jan,

day = "1",

doi = "10.1200/PO.23.00234",

language = "English",

volume = "8",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Discontinuation Syndrome With JAK2 Selective Agents

T2 - Case Presentation and Mechanistic Insights

AU - Handa, Shivani

AU - Farina, Kyle A.

AU - Becker, Michelle

AU - Kelly, Brianna

AU - Yu, Ashley

AU - Feld, Jonathan

AU - Tremblay, Douglas

AU - Marcellino, Bridget K.

AU - Salib, Christian

AU - Mascarenhas, John

AU - Shih, Alan H.

PY - 2024/1/1

Y1 - 2024/1/1

UR - https://www.scopus.com/pages/publications/85198700194

U2 - 10.1200/PO.23.00234

DO - 10.1200/PO.23.00234

M3 - Article

C2 - 38295318

AN - SCOPUS:85198700194

SN - 2473-4284

VL - 8

JO - JCO Precision Oncology

JF - JCO Precision Oncology

M1 - e2300234

ER -